Scandal-Ridden SAC Capital Buys Broadcom, Dynavax, and Boston Scientific

Might you want to buy them, too?

Mar 7, 2014 at 5:44PM

The latest 13F season has arrived, when many money managers issue required reports on their holdings. It can be worthwhile to pay attention, as you might get an investment idea or two by seeing what some major investors have been buying and selling.

For example, consider SAC Capital Advisors, run by Steven Cohen. SAC is one of the biggest hedge fund companies around, with a reportable stock portfolio totaling $17.2 billion in value as of June 30, 2013. A company doesn't generally grow that large without performing well, and indeed, Cohen has reportedly averaged returns of roughly 30% annually over two decades.

How did the hedge fund achieve its success? Well, perhaps via some insider trading. Foul play has been alleged, and the company pled guilty late last year to charges of wire fraud and securities fraud, agreeing to pay a record settlement. The company is looking into changing its name now. While you might not want to consider the managers of SAC your ethics heroes, it's not crazy to keep an eye on their investments.

SAC Capital Advisors' latest 13F report shows that it increased its holdings in Broadcom Corporation (NASDAQ:BRCM), Dynavax Technologies Corporation (NASDAQ:DVAX), and Boston Scientific Corporation (NYSE:BSX).

Communications chipmaker Broadcom, which specializes in high-speed wireless networking, improved high-quality digital video signals, and faster wired networking equipment, exceeded earnings expectations in its last quarter. Between 2012 and 2013, its revenue grew by 3.7%, and its fourth quarter brought an announcement of a 9% dividend increase, too. The company's LTE business is growing, with Samsung having recently signed on, and Broadcom has been developing chips for wearable technology such as fitness devices. Low expectations have been working in Broadcom's favor. Its stock yields 1.6%.

Dynavax, with a market capitalization near $500 million, is a smallish company that has been rather volatile in recent years. It recently collected a $5.4 million milestone payment from AstraZeneca, with which it's partnering to fight pulmonary diseases -- and if all goes well, it might collect $100 million more in future years. Dynavax has a lot riding on its adult hepatitis B vaccine Heplisav, and its future might be bright if it satisfies FDA safety concerns about the drug. Dynavax also has more formulations in its pipeline, though most are in early trial stages.

Stent and defibrillator specialist Boston Scientific topped earnings expectations in its fourth quarter, but stent sales were disappointing. Indeed, profits have been a bit elusive for the company in the past few years, though some see it successfully turning itself around. Like its peers, the company has been investing heavily in research and development, and its newer technologies, such as neurotech devices, have been paying off. Endoscopy sales recently rose 8%. Boston Scientific is looking for growth in emerging markets and plans to invest some $150 million in China. Analysts at Zacks Equity Research like its "strong pipeline of products under development."

Meet nine solid dividend payers
Dividend stocks as a group handily outperform their non-dividend-paying brethren. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.

Selena Maranjian, whom you can follow on Twitterhas no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers